Outset Medical outlines 5%–9% revenue growth for 2026 with next-gen Tablo launch and gross margin expansion (NASDAQ:OM)
Outset MedicalOutset Medical(US:OM) Seeking Alpha·2026-02-12 08:15

新闻内容分析 - 提供的文档内容不包含任何实质性的新闻、事件、财报或行业信息 文档内容仅为技术性提示 要求用户启用浏览器Javascript和Cookie 或禁用广告拦截器以继续访问 [1]

Outset Medical outlines 5%–9% revenue growth for 2026 with next-gen Tablo launch and gross margin expansion (NASDAQ:OM) - Reportify